Clinical Study of Rituximab Combined With Corticosteroids or Rituximab Monotherapy in the Treatment of Primary Membranous Nephropathy

NCT05514015 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

78

Enrollment

OTHER

Sponsor class

Conditions

Primary Membranous Nephropathy

Interventions

DRUG: rituximab combined with corticosteroids
DRUG: rituximab

Sponsor

First Affiliated Hospital, Sun Yat-Sen University